Overbrook Management’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RPRX
Overbrook Management's RPRX Position: Q3 2026 in Review
Overbrook Management sold out of Royalty Pharma (RPRX) in Q3 2026, closing a stake of 38,208 shares — an estimated $2.14M sold.
Overbrook Management first reported a position in RPRX in Q3 2020 and held it in 24 quarters. The position peaked at $39M in Q4 2020. 573 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.
- Overbrook Management reported no remaining Royalty Pharma position as of Q3 2026 after selling out during the quarter.
- Overbrook Management sold 38,208 Royalty Pharma shares in Q3 2026, an estimated $2.14M.
- Overbrook Management first reported a position in Royalty Pharma in Q3 2020 and held it in 24 quarters.
- Overbrook Management's Royalty Pharma position peaked at $39M in Q4 2020.
- 573 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.
Based on Overbrook Management's 13F filing for Q3 2026, filed 8 Oct 2026.